Cyclarity Therapeutics
Novato · Founded 2019
About Cyclarity Therapeutics
Cyclarity Therapeuitics is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic oxidized cholesterol, using computationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, macular degeneration, and liver failure. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $27.8M
- Last round: Series Unknown (Dec 2024)
- Website: https://cyclaritytx.com/
- Phone: [email protected]
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cyclarity-therapeutics-21538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.